LDLR and metabolic dysfunction-associated steatohepatitis: The study also found peroxisome proliferator-activated receptor-α (PPAR-α) and low-density lipoprotein receptor (LDLR) levels to be lower in NASH rat livers compared to the control rats, which is considered the main cause of disrupted fatty acid metabolism and liver lipidosis.